Renaissance Capital logo

Pliant Therapeutics Priced, Nasdaq: PLRX

Phase 2 biotech developing therapies for the treatment of fibrosis.

Industry: Health Care

Latest Trade: $22.07 0.00 (0.0%)

First Day Return: +33.1%

Return from IPO: +37.9%

Industry: Health Care

We are a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of TGF-ß. Our wholly-owned lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. We have completed a Phase 1a SAD/MAD trial and a Phase 1b proof-of-mechanism trial of PLN-74809 in IPF and are recruiting two Phase 2a trials in IPF. We submitted an investigational new drug application, or IND, for PLN-74809 for the treatment of PSC in March of 2020, and plan to initiate a Phase 2a PSC trial in the second half of 2020, when it is feasible to do so in light of the COVID-19 pandemic. Our second product candidate, PLN-1474, is a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with NASH, which we have partnered with Novartis. PLN-1474 is currently undergoing a Phase 1 trial with top-line data expected by the end of 2020, subject to the impact of the COVID-19 pandemic. In addition to our clinical programs, we currently have preclinical integrin-based programs targeting oncology and muscular dystrophies.
more less
IPO News for Pliant Therapeutics
more
IPO Data
IPO File Date 05/11/2020
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 9.0
Deal Size ($mm) $144
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/02/2020
Offer Price $16.00
Price Range $14.00 - $16.00
Offer Shares (mm) 9.0
Deal Size ($mm) $144
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters South San Francisco, CA
Founded 2016
Employees 62
Website www.plianttrx.com